Proteome Sciences (LON:PRM) Trading Down 12.5% – Here’s Why

Proteome Sciences plc (LON:PRM) shares were down 12.5% during trading on Thursday . The stock traded as low as GBX 3.50 ($0.05) and last traded at GBX 3.50 ($0.05). Approximately 132,133 shares were traded during mid-day trading, a decline of 44% from the average daily volume of 237,675 shares. The stock had previously closed at GBX 4 ($0.05).

Proteome Sciences Stock Performance

The company has a market capitalization of £8.91 million, a price-to-earnings ratio of -2.19 and a beta of 0.07. The firm has a fifty day simple moving average of GBX 3.37 and a 200 day simple moving average of GBX 3.49. The company has a debt-to-equity ratio of -258.66, a current ratio of 0.20 and a quick ratio of 0.37.

Proteome Sciences (LON:PRM) last released its quarterly earnings results on Thursday, April 10th. The company reported GBX (1.15) (($0.02)) earnings per share (EPS) for the quarter. Proteome Sciences had a negative net margin of 0.04% and a negative return on equity of 0.01%.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.